ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,708Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 625

$1.47M Total Retail Price of All Prescriptions

Rank: 3 out of 625

951 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 951 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 951 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

4% of this provider’s 16,533 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 1,987 921 S3 1 4
SIMVASTATIN 867 631 2 2
LEVOTHYROXINE SODIUM 640 509 3 3
LISINOPRIL 631 414 4 5
FUROSEMIDE 613 406 5 7
AMLODIPINE BESYLATE 564 432 6 1
OMEPRAZOLE 528 370 7 6
ZOLPIDEM TARTRATE 520 310 8 13
METFORMIN HCL 471 297 9 10
PRAVASTATIN SODIUM 454 350 10 8
AZITHROMYCIN 448 265 11 40
NEXIUM 446 227 12 21
TRAMADOL HCL 337 193 13 16
GABAPENTIN 329 176 14 14
LOSARTAN POTASSIUM 309 255 15 18
ATORVASTATIN CALCIUM 309 226 15 9
MELOXICAM 305 210 17 31
GLIMEPIRIDE 301 245 18 42
FLUOXETINE HCL 283 197 19 62
METOPROLOL TARTRATE 265 187 20 11
CARISOPRODOL 260 49 R 21 89
METOPROLOL SUCCINATE 249 200 22 15
POTASSIUM CHLORIDE 236 163 23 19
SERTRALINE HCL 235 153 24 26
DIOVAN HCT 234 161 25 52
CITALOPRAM HBR 226 126 26 24
ESTRADIOL 223 147 R 27 128
LISINOPRIL-HYDROCHLOROTHIAZIDE 220 130 28 27
LOSARTAN-HYDROCHLOROTHIAZIDE 215 194 29 38
HYDROCHLOROTHIAZIDE 212 111 30 12
CYMBALTA 210 56 31 46
CYCLOBENZAPRINE HCL 205 47 R 32 65
RANITIDINE HCL 182 121 33 25
CRESTOR 182 106 33 17
ALLOPURINOL 181 146 35 29
WARFARIN SODIUM 171 140 36 20
LYRICA 169 53 37 71
KLOR-CON M20 167 110 38 47
TRAZODONE HCL 166 67 39 51
ALENDRONATE SODIUM 164 140 40 34
METHYLPREDNISOLONE 162 98 41 120
CELEBREX 160 125 42 72
PANTOPRAZOLE SODIUM 159 128 43 44
DILTIAZEM ER 158 123 44 121
FLUTICASONE PROPIONATE 154 95 45 32
DIOVAN 152 117 46 28
PREMARIN 143 108 R 47 105
SYNTHROID 142 108 48 39
CLONIDINE HCL 138 78 49 50
ATENOLOL 138 126 49 22
FENTANYL 135 62 S2 51 110
DEXILANT 135 46 51 155
AMLODIPINE BESYLATE-BENAZEPRIL 133 117 53 48
CARVEDILOL 132 108 54 23
TRIAMTERENE-HCTZ 127 122 55 53
PROAIR HFA 126 56 56 57
CIPROFLOXACIN HCL 123 97 57 60
DONEPEZIL HCL 120 117 58 33
PROMETHAZINE HCL 115 26 R 59 84
CLOPIDOGREL 113 89 60 30
SYMBICORT 111 49 61 123
JANUVIA 109 78 62 74
GLYBURIDE-METFORMIN HCL 108 92 R 63 125
ZETIA 106 89 64 66
BENAZEPRIL HCL 104 80 65 35
AMITRIPTYLINE HCL 102 37 R 66 61
TAMSULOSIN HCL 98 81 67 36
PAROXETINE HCL 95 57 68 76
ESCITALOPRAM OXALATE 95 70 68 67
PLAVIX 95 62 68 43
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 59 71 116
OXYCODONE HCL-ACETAMINOPHEN 92 63 S2 72 87
LANTUS 90 54 73 54
LIPITOR 89 81 74 75
METOCLOPRAMIDE HCL 85 43 75 133
OXYCODONE HCL 82 25 S2 76 79
LEVOFLOXACIN 82 46 76 90
FLUCONAZOLE 78 35 78 165
EVISTA 78 78 78 130
TIZANIDINE HCL 77 31 80 115
PROPRANOLOL HCL 77 25 80 147
NAMENDA 75 75 82 45
INSULIN SYRINGE 73 53 83 77
ADVAIR DISKUS 73 39 83 63
ENDOCET 72 18 S2 85 124
ISOSORBIDE MONONITRATE ER 71 49 86 49
OXYCONTIN 71 0 S2 86 174
MIRTAZAPINE 70 39 88 69
VENTOLIN HFA 69 33 89 93
DIGOXIN 68 45 90 55
METFORMIN HCL ER 68 47 90 41
ENALAPRIL MALEATE 66 51 92 81
VENLAFAXINE HCL ER 66 40 92 86
VESICARE 65 47 94 193
LORAZEPAM 65 65 94 171
GLIPIZIDE ER 65 42 94 68
SINGULAIR 63 29 97 94
ACTOS 62 48 98 102
LABETALOL HCL 62 51 98 169
FENOFIBRATE 60 37 100 59
PREDNISONE 60 47 100 37
LANSOPRAZOLE 59 23 102 159
LEXAPRO 57 43 103 196
DIVALPROEX SODIUM 55 47 104 91
GLIPIZIDE XL 54 30 105 83
IBANDRONATE SODIUM 54 41 105 294
TRIAMTERENE-HYDROCHLOROTHIAZID 53 46 107 174
AMOX TR-POTASSIUM CLAVULANATE 52 36 108 135
VERAPAMIL ER 52 37 108 103
MONTELUKAST SODIUM 52 27 108 162
DILTIAZEM 24HR CD 52 40 108 131
MECLIZINE HCL 51 49 112 113
TRIAMCINOLONE ACETONIDE 51 26 112 168
DILTIAZEM 24HR ER 51 46 112 122
CEPHALEXIN 50 32 115 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.